Abstract
BackgroundThe therapeutic armamentarium for the treatment of rheumatoid arthritis (RA) has been significantly implemented with the use of biologic-disease modifying anti-rheumatic drugs (bDMARDs). TNF inhibitors (TNFi), abatacept (ABA) or tocilizumab...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have